Not exactly a prediction....because it depends on whether or not a transaction (notification of PR or no PR was actually sent by FDA to Amarin)...If there was no "confidential" and commercial transaction..then all bets are off.
If there was a transaction then I would say there was less than 10% chance the PR was not granted...No PR.... no road show....Corporations and analysts have a symbiotic relationship one hand feeds the other..Simply put Amarin could tell Chen that they has some interesting news...nothing specific...that might interest her...
If a transaction took place a few days ago...before the road show was announced...(JT probabably did not have a series of M-Day functions to attend)..If I am right (and as so many of you understand Vascepa is the poster child for a PR)...
We might be getting the announcement a little later today....
News 
Market Data 
Discover 
